Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stanton

Showing results (11-20 of 422) with videos related to

Pageof 43
Sort By:
Current Diabetes Reports|May 9, 2013
Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney diseaseRobert C Stanton
Advances in Parasitology|March 23, 2017
The Role of Spatial Statistics in the Control and Elimination of Neglected Tropical Diseases in Sub-Saharan Africa: A Focus on Human African Trypanosomiasis, Schistosomiasis and Lymphatic FilariasisM C Stanton
Current Diabetes Reports|November 8, 2008
Does blood glucose control improve vascular outcomes in patients with type 2 diabetes?Robert C Stanton
Circulation|December 17, 2013
Sodium glucose transport 2 (SGLT2) inhibition decreases glomerular hyperfiltration: is there a role for SGLT2 inhibitors in diabetic kidney disease?Robert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Frontiers in diabetic kidney disease: introductionRobert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Clinical challenges in diagnosis and management of diabetic kidney diseaseRobert C Stanton
IUBMB Life|March 21, 2012
Glucose-6-phosphate dehydrogenase, NADPH, and cell survivalRobert C Stanton
Current Diabetes Reports|December 4, 2009
Early administration of enalapril and losartan to patients with type 1 diabetesRobert C Stanton
Current Diabetes Reports|February 8, 2008
Microangiopathy in older patients with diabetes mellitusRobert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?Robert C Stanton
Pageof 43

Showing results (11-20 of 422) with videos related to

Sort By:
Pageof 43
Current Diabetes Reports|May 9, 2013
Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney diseaseRobert C Stanton
Advances in Parasitology|March 23, 2017
The Role of Spatial Statistics in the Control and Elimination of Neglected Tropical Diseases in Sub-Saharan Africa: A Focus on Human African Trypanosomiasis, Schistosomiasis and Lymphatic FilariasisM C Stanton
Current Diabetes Reports|November 8, 2008
Does blood glucose control improve vascular outcomes in patients with type 2 diabetes?Robert C Stanton
Circulation|December 17, 2013
Sodium glucose transport 2 (SGLT2) inhibition decreases glomerular hyperfiltration: is there a role for SGLT2 inhibitors in diabetic kidney disease?Robert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Frontiers in diabetic kidney disease: introductionRobert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Clinical challenges in diagnosis and management of diabetic kidney diseaseRobert C Stanton
IUBMB Life|March 21, 2012
Glucose-6-phosphate dehydrogenase, NADPH, and cell survivalRobert C Stanton
Current Diabetes Reports|December 4, 2009
Early administration of enalapril and losartan to patients with type 1 diabetesRobert C Stanton
Current Diabetes Reports|February 8, 2008
Microangiopathy in older patients with diabetes mellitusRobert C Stanton
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?Robert C Stanton
Pageof 43